These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics]. Sun KX; Wang AP; Huang LJ; Liang RC; Liu K Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954 [TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Rafie F; Javadzadeh Y; Javadzadeh AR; Ghavidel LA; Jafari B; Moogooee M; Davaran S Curr Eye Res; 2010 Dec; 35(12):1081-9. PubMed ID: 20961207 [TBL] [Abstract][Full Text] [Related]
6. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery. Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842 [TBL] [Abstract][Full Text] [Related]
7. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye. Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280 [TBL] [Abstract][Full Text] [Related]
8. Liposomes in topical drug delivery. Schaeffer HE; Krohn DL Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):220-7. PubMed ID: 7056633 [TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of ocular anti-inflammatory drugs based on measurements of corneal temperature in rabbits: dexamethasone and glycyrrhizin. Tanaka H; Hasegawa T; Matsushita M; Miichi H; Hayashi S Ophthalmic Res; 1987; 19(4):213-20. PubMed ID: 3501091 [TBL] [Abstract][Full Text] [Related]
10. Assessment of ocular irritability of liposome preparations. Taniguchi K; Yamamoto Y; Itakura K; Miichi H; Hayashi S J Pharmacobiodyn; 1988 Sep; 11(9):607-11. PubMed ID: 3216282 [TBL] [Abstract][Full Text] [Related]
11. Drug interaction in the eye. Concurrent corticosteroid-antibiotic therapy for inflammatory keratitis. Leibowitz HM; Kupferman A Arch Ophthalmol; 1977 Apr; 95(4):682-5. PubMed ID: 192185 [TBL] [Abstract][Full Text] [Related]
12. [An anti-phlogistic effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine) on experimentally induced ocular inflammation]. Asayama R; Tsukahara I; Sakaue E; Fukuchi S; Suga K Nihon Ganka Kiyo; 1966 Feb; 17(2):89-101. PubMed ID: 6006623 [No Abstract] [Full Text] [Related]
13. Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model. Mirabelli P; Peebo BB; Xeroudaki M; Koulikovska M; Lagali N Exp Eye Res; 2014 Aug; 125():118-27. PubMed ID: 24933712 [TBL] [Abstract][Full Text] [Related]
14. Ocular distribution of liposome-encapsulated epinephrine and inulin in the albino rabbit. Stratford RE; Yang DC; Redell MA; Lee VH Curr Eye Res; 1982-1983; 2(6):377-86. PubMed ID: 7188304 [TBL] [Abstract][Full Text] [Related]
15. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation. Chono S; Morimoto K J Pharm Pharmacol; 2006 Sep; 58(9):1219-25. PubMed ID: 16945180 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium. Kupferman A; Leibowitz HM Invest Ophthalmol; 1975 Mar; 14(3):252-5. PubMed ID: 1116925 [TBL] [Abstract][Full Text] [Related]
17. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery. Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone. Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466 [TBL] [Abstract][Full Text] [Related]
19. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome. Hashida N; Ohguro N; Yamazaki N; Arakawa Y; Oiki E; Mashimo H; Kurokawa N; Tano Y Exp Eye Res; 2008 Jan; 86(1):138-49. PubMed ID: 18036523 [TBL] [Abstract][Full Text] [Related]
20. Sialic Acid Conjugate-Modified Liposomal Dexamethasone Palmitate Targeting Neutrophils for Rheumatoid Arthritis Therapy: Influence of Particle Size. Wang S; Yang S; Lai X; Song Y; Hu L; Li C; Shi T; Liu X; Deng Y; Chen G AAPS PharmSciTech; 2021 Jan; 22(1):16. PubMed ID: 33389218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]